Clinical Social Workers in St. Thomas, VI Accepting Medicare

3 Clinical Social Workers found. Showing 1 - 3

Nisha Karese Jones, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 9160 Estate Thomas Pmb 2120, St. Thomas, VI 00802 Phone: 340-514-0256

Ms. Juliette M Millin, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 12 Estate Sorgenfri, St. Thomas, VI 00802 Phone: 340-513-0244    Fax: 340-776-8216

Michelle S Mcgowan, MSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: Adult Protective Services Knude Hanson Comples Bldg. A, 1303 Hospital Ground, St. Thomas, VI 00802 Phone: 340-774-0930

News Archive

Lawmakers, others worry about stimulus funds, Medicaid money

As federal stimulus funds begin to run out, including enhanced federal support for swelling Medicaid rolls, lawmakers and others are worried that the U.S. economy could again stall. "[M]any important programs are losing funding. Among the most crucial is unemployment insurance. … Stimulus funds have also helped subsidize health benefits through the Consolidated Omnibus Budget Reconciliation Act, or COBRA, which gives jobless workers an opportunity to continue their coverage at group rates for a limited time. Efforts to extend those provisions are stalled in Congress. The National Employment Law Project estimates that 1.63 million workers will exhaust their benefits by the end of this week, and at least 140,000 workers will lose COBRA coverage."

New molecule could become first treatment against chemotherapy-induced neuropathy

IDIBELL Researchers of the Neuro-Oncology Unit of Bellvitge University Hospital - Catalan Institute of Oncology, led by Dr. Jordi Bruna, have successfully tested a new molecule capable of preventing the development of peripheral neuropathy induced by chemotherapy in cancer patients, especially in colon cancer cases, the third most common neoplasm in the world.

Bionovo granted additional grace period for regaining compliance with NASDAQ's minimum bid requirement

Bionovo, Inc. today announced that on March 16, 2010, the Company received a letter from NASDAQ stating that the Company has been granted an additional 180 day grace period, until September 13, 2010, to regain compliance with the minimum bid price of $1.00 required for continued listing on the NASDAQ Capital Market.

Wild Mediterranean plant provides potential anticancer medicines

A group of scientists from the Department of Organic Chemistry and the Biotechnology Institute of the University of Granada have found out that the plant "Dittirichia viscose", known as elecampe, can be used to obtain inhibitors of neurogenic vasodilatation, a significant progress in migraine and cancer treatments.

Read more Medical News

› Verified 6 days ago